中华医学杂志（英文版）2013，Vol.126Issue(13)：2403-2408,6.DOI:10.3760/cma.j.issn.0366-6999.20130261
Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial
Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial
WANG Zi-kai 1YANG Yun-sheng 1CAI Feng-chun 1WANG Yong-hua 1SHI Xiao-lin 1DING Chen 1LI Wen1
作者信息
- 1. Department of Gastroenterology and Hepatology, Chinese People's Liberation Army General Hospital, Beijing 100853, China
- 折叠
摘要
关键词
somatostatin/ endoscopic retrograde cholangiopancreatography/ post-endoscopic retrograde cholangiopancreatography pancreatitis / hyperamylasemiaKey words
somatostatin/ endoscopic retrograde cholangiopancreatography/ post-endoscopic retrograde cholangiopancreatography pancreatitis / hyperamylasemia引用本文复制引用
WANG Zi-kai,YANG Yun-sheng,CAI Feng-chun,WANG Yong-hua,SHI Xiao-lin,DING Chen,LI Wen..Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial[J].中华医学杂志（英文版）,2013,126(13):2403-2408,6.
